ArticleJCO precision oncology2019

Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia.

Roberta La Starza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.